RUNX1 and myelodysplastic syndrome: These Evi1-transgenic mice developed a disease resembling myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN), characterized by anemia and thrombocytopenia, accompanied by an expansion of myelopoiesis and suppressed lymphopoiesis.